168 related articles for article (PubMed ID: 33359585)
1. A High Proportion of Canadian Allergists Offer Oral Immunotherapy but Barriers Remain.
Mack DP; Soller L; Chan ES; Hanna MA; Terpstra C; Vander Leek TK; Bégin P
J Allergy Clin Immunol Pract; 2021 May; 9(5):1902-1908. PubMed ID: 33359585
[TBL] [Abstract][Full Text] [Related]
2. Food Oral Immunotherapy: A Survey Among US Practicing Allergists Conducted as a AAAAI Leadership Institute Project and Work Group Report.
Anagnostou A; Vickery B
J Allergy Clin Immunol Pract; 2023 Aug; 11(8):2330-2334. PubMed ID: 37236350
[TBL] [Abstract][Full Text] [Related]
3. Update on peanut allergy: Prevention and immunotherapy.
Cook QS; Kim EH
Allergy Asthma Proc; 2019 Jan; 40(1):14-20. PubMed ID: 30582491
[No Abstract] [Full Text] [Related]
4. Oral and Sublingual Immunotherapy for Treatment of IgE-Mediated Food Allergy.
Scurlock AM
Clin Rev Allergy Immunol; 2018 Oct; 55(2):139-152. PubMed ID: 29656306
[TBL] [Abstract][Full Text] [Related]
5. An Approach to the Office-Based Practice of Food Oral Immunotherapy.
Wasserman RL; Factor J; Windom HH; Abrams EM; Begin P; Chan ES; Greenhawt M; Hare N; Mack DP; Mansfield L; Ben-Shoshan M; Stukus DR; Leek TV; Shaker M
J Allergy Clin Immunol Pract; 2021 May; 9(5):1826-1838.e8. PubMed ID: 33684637
[TBL] [Abstract][Full Text] [Related]
6. Allergist-reported trends in the practice of food allergen oral immunotherapy.
Greenhawt MJ; Vickery BP
J Allergy Clin Immunol Pract; 2015; 3(1):33-8. PubMed ID: 25577615
[TBL] [Abstract][Full Text] [Related]
7. Current management and use of oral immunotherapy in the United States for patients with peanut allergy.
Blaiss MS; Tilles S; Petroni D; Zigmont E; Cassese M; Kwak B; Georgitseas N; Liebermann J
Allergy Asthma Proc; 2019 Jul; 40(4):214-220. PubMed ID: 31122310
[No Abstract] [Full Text] [Related]
8. Advances, Practical Implementation, and Unmet Needs Regarding Oral Immunotherapy for Food Allergy.
Perrett KP; Sindher SB; Begin P; Shanks J; Elizur A
J Allergy Clin Immunol Pract; 2022 Jan; 10(1):19-33. PubMed ID: 34785391
[TBL] [Abstract][Full Text] [Related]
9. How We Manage Gastrointestinal Symptoms During Oral Immunotherapy Through a Shared Decision-Making Process-A Practical Guide for the Community Practitioner.
Chua GT; Chan ES; Invik R; Soller L; Avinashi V; Erdle SC; Wong T; Cook VE; Mak R; Cameron SB
J Allergy Clin Immunol Pract; 2023 Apr; 11(4):1049-1055. PubMed ID: 36470519
[TBL] [Abstract][Full Text] [Related]
10. Validated anxiety assessments among pediatric patients with peanut allergy on oral immunotherapy.
Kaman K; Dhodapkar M; Shabanova V; McCollum S; Factor J; Leeds S
Ann Allergy Asthma Immunol; 2023 May; 130(5):657-663. PubMed ID: 36738780
[TBL] [Abstract][Full Text] [Related]
11. Oral and sublingual peanut immunotherapy is not ready for general use.
Greenhawt MJ
Allergy Asthma Proc; 2013; 34(3):197-204. PubMed ID: 23676568
[TBL] [Abstract][Full Text] [Related]
12. Oral immunotherapy for peanut allergy: multipractice experience with epinephrine-treated reactions.
Wasserman RL; Factor JM; Baker JW; Mansfield LE; Katz Y; Hague AR; Paul MM; Sugerman RW; Lee JO; Lester MR; Mendelson LM; Nacshon L; Levy MB; Goldberg MR; Elizur A
J Allergy Clin Immunol Pract; 2014; 2(1):91-6. PubMed ID: 24565775
[TBL] [Abstract][Full Text] [Related]
13. Qualitative interviews to understand health care providers' experiences of prescribing licensed peanut oral immunotherapy.
Anagnostou A; Lawrence C; Tilles SA; Laubach S; Donelson SM; Yassine M; Nowak-Wegrzyn A
BMC Res Notes; 2022 Aug; 15(1):273. PubMed ID: 35941597
[TBL] [Abstract][Full Text] [Related]
14. First Real-World Safety Analysis of Preschool Peanut Oral Immunotherapy.
Soller L; Abrams EM; Carr S; Kapur S; Rex GA; Leo S; Lidman PG; Yeung J; Vander Leek TK; McHenry M; Wong T; Cook VE; Hildebrand KJ; Gerstner TV; Mak R; Lee NJ; Cameron SB; Chan ES
J Allergy Clin Immunol Pract; 2019; 7(8):2759-2767.e5. PubMed ID: 31002957
[TBL] [Abstract][Full Text] [Related]
15. Implementation of the Addendum Guidelines for Peanut Allergy Prevention by US allergists, a survey conducted by the NIAID, in collaboration with the AAAAI.
Johnson JL; Gupta RS; Bilaver LA; Hu JW; Martin J; Jiang J; Bozen A; Davis MM; Reese J; Cooper S; Togias A; Arbes SJ
J Allergy Clin Immunol; 2020 Oct; 146(4):875-883. PubMed ID: 32745556
[TBL] [Abstract][Full Text] [Related]
16. Efficacy, Safety, and Quality of Life in a Multicenter, Randomized, Placebo-Controlled Trial of Low-Dose Peanut Oral Immunotherapy in Children with Peanut Allergy.
Blumchen K; Trendelenburg V; Ahrens F; Gruebl A; Hamelmann E; Hansen G; Heinzmann A; Nemat K; Holzhauser T; Roeder M; Rosenfeld L; Hartmann O; Niggemann B; Beyer K
J Allergy Clin Immunol Pract; 2019 Feb; 7(2):479-491.e10. PubMed ID: 30423449
[TBL] [Abstract][Full Text] [Related]
17. Food allergy immunotherapy: Oral immunotherapy and epicutaneous immunotherapy.
Kim EH; Burks AW
Allergy; 2020 Jun; 75(6):1337-1346. PubMed ID: 32034781
[TBL] [Abstract][Full Text] [Related]
18. Study protocol of a multicentre, randomised, controlled trial evaluating the effectiveness of probiotic and peanut oral immunotherapy (PPOIT) in inducing desensitisation or tolerance in children with peanut allergy compared with oral immunotherapy (OIT) alone and with placebo (the PPOIT-003 study).
Chebar Lozinsky A; Loke P; Orsini F; O'Sullivan M; L Prescott S; Gold MS; Quinn P; DunnGalvin A; Lk Tang M;
BMJ Open; 2020 Sep; 10(9):e035871. PubMed ID: 32912942
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of allergen-specific immunotherapy for peanut allergy: a meta-analysis of randomized controlled trials.
Sun J; Hui X; Ying W; Liu D; Wang X
Allergy Asthma Proc; 2014; 35(2):171-7. PubMed ID: 24717795
[TBL] [Abstract][Full Text] [Related]
20. Clinical studies in oral allergen-specific immunotherapy: differences among allergens.
Sato S; Yanagida N; Ogura K; Imai T; Utsunomiya T; Iikura K; Goto M; Asaumi T; Okada Y; Koike Y; Syukuya A; Ebisawa M
Int Arch Allergy Immunol; 2014; 164(1):1-9. PubMed ID: 24943470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
